The Current State of Biosimilars: A focus on the background, utilization, and post-surveillance initiates currently ongoing in the United States

1.0 Hours of CE for Pharmacists and Pharmacy Technicians

After watching this program, pharmacists and pharmacy technicians will be able to:

  1. Describe the current biosimilar marketplace and how it compared with the generic drug uptake in the United States.
  2. Explain the limitations of clinical trial data in supporting real world clinical and economic decision making.
  3. Describe what post-marketing data are needed to assess biosimilar safety and efficacy and initiatives that have been created to study these issues.


To obtain CE credit for this program:

Continuing Education Videos

Learning Materials and Handouts

PDF of Presentation PowerPoint 

CE Quiz

Take Quiz

Fees (Register Here)

  • $25 for VPhA Members
  • $50 for Non-Members

Faculty Information

  • Mark Cziraky, PharmD, CLS – Vice President of Research HealthCore

Continuing Education Information

ACPE # 0278-0000-18-038-H04-P
ACPE # 0278-0000-18-038-H04-T
1.0 Contact Hours (0.10 CEU) for Pharmacists & Pharmacy Technicians
Knowledge Based
Program expiration date: 12/20/2021

Program Sponsorship

Program sponsored in part by:

  • VPhA Research & Education Foundation

Speaker Disclosures

VPhA requires that speakers disclose real or apparent conflict of interest relating to the topics of the educational activity.

Conflict of Interest forms are on file at the VPhA office.

The Virginia Pharmacists Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.